ReviewCurrent urology reports2017
Performance of
Review in Current urology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 29 citations in OpenAlex.
- Trial
- Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated withEuropean journal of nuclear medicine and molecular imaging · 2020Trial
- Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer.Molecules (Basel, Switzerland) · 2026Article
- Review
- Convoluted Neural Network for Detection of Clinically Significant Prostate Cancer onNuclear medicine and molecular imaging · 2024Article
- Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer.Diagnostics (Basel, Switzerland) · 2023Review
- Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends.Cancers · 2021Review
- Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical review.Translational andrology and urology · 2020Review
- Deep neural network for automatic characterization of lesions onEuropean journal of nuclear medicine and molecular imaging · 2020Article
- Article
- Article
- Review
- Clinical implications of PET/CT in prostate cancer management.Translational andrology and urology · 2018Review
- Advances in prostate-specific membrane antigen PET of prostate cancer.Current opinion in oncology · 2018Review
- Accuracy of tumor segmentation from multi-parametric prostate MRI andEJNMMI research · 2018Article
- Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.Diagnostics (Basel, Switzerland) · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of the reviewRecently introduced Gallium-68 labeled PSMA-ligands such as HBED-CC ( RECENT
findings
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.